Park Medi World Limited is significantly expanding its footprint in the Tricity region by launching a new multi-super specialty hospital in Panchkula and expanding its Mohali facility. The Panchkula hospital, expandable to 350 beds, will commence operations on March 29, 2026. Additionally, the company will add 150 beds to its existing 350-bed Mohali facility with an investment of Rs. 40 crores funded via internal accruals. These moves will establish the company as the largest private healthcare provider in the region with a total of 850 beds.

Park Medi World is significantly expanding its footprint in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. Additionally, the board has approved a 150-bed expansion at its Mohali facility, which currently operates at 73% capacity, bringing the total regional capacity to 850 beds. The Mohali expansion involves an investment of approximately Rs. 40 crores, which will be entirely funded through internal accruals. This strategic move is expected to make the company the largest private healthcare network in the Tricity area, focusing on high-margin tertiary and quaternary care.

Park Medi World is significantly scaling its presence in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. The board also approved a 150-bed expansion at its Mohali subsidiary, increasing its capacity from 350 to 500 beds with a Rs. 40 crore investment. These developments will bring the company's total regional capacity to 850 beds, establishing it as the largest private healthcare network in the area. The expansion is strategically funded through internal accruals and targets high-margin quaternary care services.

Park Medi World reported a robust performance for 9M FY26, with revenue growing 17% YoY to ₹12,189 million and PAT increasing 40% to ₹1,968 million. The company is executing an aggressive expansion strategy, aiming to increase its bed capacity from 3,250 to 5,260 by FY28 through a mix of greenfield and brownfield projects. Operational efficiency improved as ARPOB rose to ₹27,406 and occupancy reached 65% despite the addition of new beds. Management targets a long-term EBITDA margin of 27% and an ROCE of 21%.

Park Medi World reported a strong Q3 FY26 with revenue growing 17.76% YoY to ₹4,100 million and PAT increasing 15.78% to ₹528 million. The 9-month performance was particularly robust, with PAT surging 42.6% YoY to ₹1,968 million, supported by a 65% occupancy rate and improved operational efficiencies. The company aggressively expanded its footprint by acquiring KP Institute of Medical Sciences in Agra for ₹245 crore and Febris Hospital in Delhi. Management remains committed to a cluster-based expansion model, targeting a total capacity of 5,260 beds by March 2028.

Park Medi World reported a strong Q3 FY26 with revenue growing 17.76% YoY to ₹4,100 million and PAT increasing 15.78% to ₹528 million. The company maintained healthy EBITDA margins at 24.25% while integrating new capacities. Strategic growth was highlighted by the ₹245 crore acquisition of KP Institute in Agra and Febris Hospital in Delhi, bringing current bed capacity to 3,250. The management is executing a cluster-based expansion strategy with a target of 5,260 beds by March 2028.

Park Medi World reported a strong Q3 FY26 with revenue growing 18% YoY to ₹4,100 million and PAT increasing 16% to ₹528 million. The 9-month performance was even more robust, with PAT surging 43% YoY to ₹1,968 million, driven by improved occupancy of 65% and higher ARPOB of ₹27,406. The company is aggressively expanding its footprint, having recently acquired 560 beds through Febris Hospital and KPIMS. Management aims to reach a total capacity of 5,260 beds by March 2028, positioning the firm as a dominant player in North India.

Park Medi World Limited reported its first financial results post-listing, with Q3 FY26 consolidated revenue reaching ₹3,670.96 million and a net profit of ₹368.78 million. The company is aggressively pursuing inorganic growth, announcing acquisitions of K P S Wellness and SVPD Healthcare for ₹2,450 million, and Krishna Super-Speciality Hospital for ₹400 million. For the nine-month period ended December 2025, the group achieved a robust net profit of ₹1,671.67 million. IPO proceeds are being actively deployed, with ₹2,225.90 million already utilized for debt repayment and capital expenditure.

Park Medi World Limited has successfully acquired 100% shareholding of Mahip Hospitals Private Limited, which operates the 250-bed Krishna Super-speciality Hospital in Bathinda, for ₹40 crore. The company had been managing the facility since July 2025 and has now transitioned to full ownership to drive operational synergies. The target hospital demonstrated strong growth, with turnover rising from ₹7.73 crore in FY24 to ₹16 crore in FY25. This acquisition is a strategic step toward the company's goal of reaching a total capacity of 5,260 beds by March 2028.

Park Medi World Limited has approved the 100% acquisition of Mahip Hospitals Private Limited, which operates the 250-bed Krishna Super-speciality Hospital in Bathinda. The acquisition is valued at an aggregate cash consideration of up to INR 40 crore. The target hospital has shown rapid growth, with turnover increasing from INR 7.73 crore in FY24 to INR 16.00 crore in FY25. This acquisition is a strategic step toward the company's goal of reaching a total capacity of 5,260 beds by March 2028.

Park Medi World Limited, through its subsidiary Blue Heavens Health Care, has acquired 100% of Durha Vitrak Private Limited, which owns the 200-bed Febris Multi-speciality Hospital in Narela, Delhi. The acquisition was executed via the NCLT insolvency resolution process for a total consideration of Rs 50.68 crore. This facility, spanning 1,10,000 sq ft, has been non-operational since 2019 and will now be integrated into the Park Group network. The move is a key part of the company's strategy to expand its total capacity from 3,250 beds to 5,260 beds by March 2028.